SCHEMBL20599646

SCHEMBL20599646

CCOC(=O)OC(=O)C1CCOC1

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.45
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.35
PPM1B O75688 1/20 0.35
PTPN1 P18031 1/20 0.35
PPP1CC P36873 1/20 0.35
MAPT P10636 3/20 0.34
ACACB O00763 1/20 0.34
GAA P10253 3/20 0.33
POLB P06746 1/20 0.33
HIF1A Q16665 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666182 0.86 MAPT (0.45) ALDH1A1TSHRPPM1BPTPN1PPP1CC
SCHEMBL2565618 0.82 SOAT1 (0.61) SOAT1ALDH1A1PPM1BPTPN1PPP1CC
Hydrochloric Acid SCHEMBL27534001 0.80 SOAT1 (0.58) SOAT1ALDH1A1PPM1BPTPN1PPP1CC
SCHEMBL6153652 0.77 SOAT1 (0.54) SOAT1ALDH1A1PPM1BPTPN1PPP1CC
SCHEMBL7660003 0.76 PPM1B (0.45) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL11301518 0.76 ALDH1A1 (0.47) ALDH1A1TSHRPPM1BPTPN1PPP1CC
SCHEMBL27549861 0.75 ALDH1A1 (0.54) SOAT1ALDH1A1TSHRMAPTGAA
Hydrochloric Acid SCHEMBL28100636 0.75 SOAT1 (0.52) SOAT1ALDH1A1PPM1BPTPN1PPP1CC
SCHEMBL72855 0.74 MAPT (0.51) ALDH1A1TSHRPPM1BPTPN1PPP1CC
Hydrochloric Acid SCHEMBL27578586 0.74 ALDH1A1 (0.53) SOAT1ALDH1A1TSHRMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645516-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS Janssen Pharmaceutica NV (BE) 2020-05-06 EP disclosed
WO-2019001420-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed